DTU - Technical University of Denmark
The Novo Nordisk Foundation Center for Biosustainability (CfB) at the Technical University of Denmark (DTU) aims at developing new knowledge and technologies to help facilitite the transformation from the existing oil-based chemical industry to a more sustainable bio-based society, in which chemicals are produced biologically. CfB focuses on conducting research in developing the next generation of production organisms, cell factories for the sustainable and economically feasible bioproduction of chemical compounds and for improved production of therapeutic proteins. The center does this by using advaned metabolic engineering techniques and taking advantage of genome-scale science. The research at CfB is currently focused on three different model organisms, S.cerevisiae, E. coli for the production of valuable chemicals and CHO-cell lines for the production of therapeutic proteins.
University of Groningen, the Netherlands
The university of Groningen, founded in 1614, enjoys an international reputation as one of the oldest and leading research universityes in Europe. One of its scientific spearheads is the cluster of biologiest, chemists and physicists that actively collaborate to unravel fundamental understanding of natural processes and to exploit this knowledge for building designs and devices for novel applications. These activities are focused in the university's "Centre of Synthetic Biology", which focusses on innovative and curiosity-driven research with exploiting novel findings also for applications. The intensive collaboration in research and teaching fo this group of researchers facilitiated the success of the Groningen iGEM team, which became world champion in the 2012 competition. The Moleculars Systems Biology group - the partner in this consortium - is a member of the Centre for Synthetic Biology and formally part of the Groningen Biomolecular Science and Biotechnology Institute whose main aim is to generate fundamental understanding about microbial processes and re-engineering of such processes.
Technische Universität Darmstadt, Germany
The Technische Universität Darmstadt is one of Germany's leading technical universities. The wide variety of disciplines represented are all focused on technology, as viewed from the vantage of point of enginerring, and covere the full range of academic endeavor, from the origination of basic concepts to practical, everyday applications. TUDA is Germany's first autonomous university and one of Germany's leading academic recipients of outside funding. The faculty of biology is located at the moderns campus "Lichtwiese". One of the two main research focuses of the faculty is "Synthetic Biology" with the 2011 established chair for "Synthetic Genetic Circuits", helt by Prof. Suess. The faculty offers a master in "Technical biology" and "Biomolecular Engineering".
Bacmine SL, Spain
Bacmine SL is a synthetic biology R&D company that designs and develops Bacterial Cell Factories for production of customized bioactive molecules and whole-cell catalysis. Bacmine was founded in 2011 by scientists from the Centro Nacional de Biotechologia (CNB-CSIC, Madrid-Spain). The company's mission is to provide solutions to industry by the invention and development of novel bacterial strains with customised functions. Bacmine's reference laboratoies and staff researchers have made acknowledged fundamental and technical contributions directly applicable to the development of this project, specifically on development of genetic tools for analysis and construcion of complex phenotypes in bacteria.
The University of Warwick
The University of Warwick consistently ranks in the top ten of all major rankings of British universities and it is the only multi-faculty institution aside from the Universities of Oxford and Cambridge to have never been ranked outside the top ten. It was ranked as the third best "young" university in the world, and the best in Europe. It is the best university under 50 years of age in Europe, and third best under 50 years of age in the world. The School of Life Sciences is home to a wide range of exciting interdisciplinary bioscience. Research in the School ranges from molecular through cellular to the organism level and spans bacteria, viruses, fungi, protists, animals and plants.
Evolva SA, Switzerland
Evolva's mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. Evolva uses synthetic biology and evolutionary technologies to create and optimise small molecule compounds and their production. They are active in consumer healthcare and nutrition (food ingredients, personal care and crop protection) as well as in pharma (infectious disease and complications of diabetes). In both areas we have partnered as well as proprietary projects. Evolva is listed on the Swiss Stock Exchange (ticker EVE) and has operations in Basel (Switzerland), Chennai (India), Copenhagen (Denmark) and the San Francisco Bay Area (USA).
Biosyntia is a synthetic biolgy start-up, founded by globally leading life science investors. Biosyntia develops bio-based production processes through its unique platform for creating cell factories for production of fine chemicals. By employing these cell factories chemical manufacturers will be able to save up to 80% on direct production costs and reduce their environmental impact substantially. Biosyntia can develop cell factories at unprecedented speed and efficiency due to our superios high-throughput screening technology, Riboselect.